Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease

Objective. We aimed at analyzing the role of smoking in hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) and at exploring the related risk factors. Methods. This was a cross-sectional study that included a total of 225 patients with NAFLD. Among them, 127 were nonsmokers an...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongjie Ou, Yaojie Fu, Wei Liao, Caixia Zheng, Xiaolu Wu
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2019/6028952
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556612249714688
author Hongjie Ou
Yaojie Fu
Wei Liao
Caixia Zheng
Xiaolu Wu
author_facet Hongjie Ou
Yaojie Fu
Wei Liao
Caixia Zheng
Xiaolu Wu
author_sort Hongjie Ou
collection DOAJ
description Objective. We aimed at analyzing the role of smoking in hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) and at exploring the related risk factors. Methods. This was a cross-sectional study that included a total of 225 patients with NAFLD. Among them, 127 were nonsmokers and 98 were smokers. Liver significant fibrosis was diagnosed when the liver stiffness (LS) value was higher than 7.4 kPa. The diagnostic criterion for NAFLD was a controlled attenuation parameter (CAP) value of >238 dB/m. The CAP and LS values were measured using FibroScan. Results. FibroScan showed that the LS value in the smokers was significantly higher than that in the nonsmokers (10.12 ± 10.38 kPa vs. 7.26 ± 6.42 kPa, P=0.013). The proportions of patients with liver significant fibrosis and advanced liver fibrosis among the smokers were significantly higher than those among the nonsmokers (P=0.046). Univariate analysis showed that age, weight, high AST level, low PLT level, and smoking were the risk factors associated with liver fibrosis in the smokers with NAFLD while multivariate analysis showed that age (OR = 1.029, P=0.021), high AST level (OR = 1.0121, P=0.025), and smoking (OR = 1.294, P=0.015) were the independent risk factors associated with liver fibrosis in the patients with NAFLD. Moreover, high AST level (OR = 1.040, P=0.029), smoking index (OR = 1.220, P=0.019), and diabetes mellitus (OR = 1.054, P=0.032) were the independent risk factors for liver fibrosis among the smokers with NAFLD. Conclusion. This study showed that smoking was closely associated with liver fibrosis among the patients with NAFLD. For patients with NAFLD who smoke, priority screening and timely intervention should be provided if they are at risk of liver fibrosis.
format Article
id doaj-art-6265d6834c814c76a68d396d16308386
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-6265d6834c814c76a68d396d163083862025-02-03T05:44:45ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972019-01-01201910.1155/2019/60289526028952Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver DiseaseHongjie Ou0Yaojie Fu1Wei Liao2Caixia Zheng3Xiaolu Wu4Department of Infectious Diseases, First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaEmergency Department, First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaIntensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Infectious Diseases, First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaDepartment of Infectious Diseases, First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaObjective. We aimed at analyzing the role of smoking in hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) and at exploring the related risk factors. Methods. This was a cross-sectional study that included a total of 225 patients with NAFLD. Among them, 127 were nonsmokers and 98 were smokers. Liver significant fibrosis was diagnosed when the liver stiffness (LS) value was higher than 7.4 kPa. The diagnostic criterion for NAFLD was a controlled attenuation parameter (CAP) value of >238 dB/m. The CAP and LS values were measured using FibroScan. Results. FibroScan showed that the LS value in the smokers was significantly higher than that in the nonsmokers (10.12 ± 10.38 kPa vs. 7.26 ± 6.42 kPa, P=0.013). The proportions of patients with liver significant fibrosis and advanced liver fibrosis among the smokers were significantly higher than those among the nonsmokers (P=0.046). Univariate analysis showed that age, weight, high AST level, low PLT level, and smoking were the risk factors associated with liver fibrosis in the smokers with NAFLD while multivariate analysis showed that age (OR = 1.029, P=0.021), high AST level (OR = 1.0121, P=0.025), and smoking (OR = 1.294, P=0.015) were the independent risk factors associated with liver fibrosis in the patients with NAFLD. Moreover, high AST level (OR = 1.040, P=0.029), smoking index (OR = 1.220, P=0.019), and diabetes mellitus (OR = 1.054, P=0.032) were the independent risk factors for liver fibrosis among the smokers with NAFLD. Conclusion. This study showed that smoking was closely associated with liver fibrosis among the patients with NAFLD. For patients with NAFLD who smoke, priority screening and timely intervention should be provided if they are at risk of liver fibrosis.http://dx.doi.org/10.1155/2019/6028952
spellingShingle Hongjie Ou
Yaojie Fu
Wei Liao
Caixia Zheng
Xiaolu Wu
Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
Canadian Journal of Gastroenterology and Hepatology
title Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
title_full Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
title_fullStr Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
title_full_unstemmed Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
title_short Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
title_sort association between smoking and liver fibrosis among patients with nonalcoholic fatty liver disease
url http://dx.doi.org/10.1155/2019/6028952
work_keys_str_mv AT hongjieou associationbetweensmokingandliverfibrosisamongpatientswithnonalcoholicfattyliverdisease
AT yaojiefu associationbetweensmokingandliverfibrosisamongpatientswithnonalcoholicfattyliverdisease
AT weiliao associationbetweensmokingandliverfibrosisamongpatientswithnonalcoholicfattyliverdisease
AT caixiazheng associationbetweensmokingandliverfibrosisamongpatientswithnonalcoholicfattyliverdisease
AT xiaoluwu associationbetweensmokingandliverfibrosisamongpatientswithnonalcoholicfattyliverdisease